Literature DB >> 11531896

Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat.

M G Jones1, I Lever, S Bingham, S Read, S B McMahon, A Parsons.   

Abstract

Infusing glyceryl trinitrate as a donor molecule, we have used electrophysiological and c-fos immunostaining techniques to study the effects of nitric oxide on neurones in the nucleus trigeminalis caudalis. Following infusion of glyceryl trinitrate, responses of neurones to electrical stimulation of periorbital cutaneous afferents were potentiated and threshold for activation of neurones by stimulation of dural afferents was reduced. Expression of c-fos was unchanged by glyceryl trinitrate compared to saline controls. Intradermal injection of capsaicin in the periorbital area increased c-fos expression in nucleus trigeminalis caudalis; this was significantly potentiated by glyceryl trinitrate. These results suggest that, in the anaesthetized rat, glyceryl trinitrate alone may not acutely activate the trigeminovascular system to a significant degree at doses that cause headache and later trigger migraine headache in migraineurs. Nevertheless, it is susceptible to exogenous nitric oxide in that activation of trigeminal neurones through cutaneous or dural pathways is potentiated. This may in some measure underlie the pathogenesis of migraine headache.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531896     DOI: 10.1046/j.1468-2982.2001.00213.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  13 in total

Review 1.  Nitric oxide-related drug targets in headache.

Authors:  Jes Olesen
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

2.  Inhibition of the PKCγ-ε pathway relieves from meningeal nociception in an animal model: an innovative perspective for migraine therapy?

Authors:  Nicoletta Galeotti; Carla Ghelardini
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

3.  Long-Term Depression Induced by Optogenetically Driven Nociceptive Inputs to Trigeminal Nucleus Caudalis or Headache Triggers.

Authors:  Bruno Pradier; Hye Bin Shin; Duk Soo Kim; Robyn St Laurent; Diane Lipscombe; Julie A Kauer
Journal:  J Neurosci       Date:  2018-07-27       Impact factor: 6.167

Review 4.  Pathophysiology of headache.

Authors:  Margarita Sánchez del Río; Uwe Reuter
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

5.  Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway.

Authors:  Mária Dux; Christine Will; Birgit Vogler; Milos R Filipovic; Karl Messlinger
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

6.  Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors.

Authors:  XiChun Zhang; Vanessa Kainz; Jun Zhao; Andrew M Strassman; Dan Levy
Journal:  Ann Neurol       Date:  2013-06-17       Impact factor: 10.422

7.  Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia.

Authors:  Cristina Tassorelli; Rosaria Greco; Giorgio Sandrini; Giuseppe Nappi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels.

Authors:  S Akerman; D J Williamson; H Kaube; P J Goadsby
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

9.  Episodic dural stimulation in awake rats: a model for recurrent headache.

Authors:  Michael L Oshinsky; Sumittra Gomonchareonsiri
Journal:  Headache       Date:  2007 Jul-Aug       Impact factor: 5.887

10.  Microglia P2X4 receptor contributes to central sensitization following recurrent nitroglycerin stimulation.

Authors:  Ting Long; Wei He; Qi Pan; Shanshan Zhang; Yixin Zhang; Chaoyang Liu; Qing Liu; Guangcheng Qin; Lixue Chen; Jiying Zhou
Journal:  J Neuroinflammation       Date:  2018-08-30       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.